Skip to content

Prospective cohort study of thrombotic biomarker lineage in gastric cancer patients and establishment of VTE prediction model

Prospective cohort study of thrombotic biomarker lineage in gastric cancer patients and establishment of VTE prediction model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126212
Enrollment
Unknown
Registered
2026-06-05
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Observation group:None

Sponsors

Shandong Provincial Qianfoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Age >= 18 years old; 2.Diagnosed with gastric cancer through pathology or imaging; 3.Plan to receive anti-tumor treatments such as chemotherapy, targeted therapy, immunotherapy, or surgery; 4.No active bleeding; 5.Not receiving prophylactic or therapeutic anticoagulant drugs; 6.Expected survival period >= 3 months; 7.The patient or legal representative signs a written informed consent form;

Exclusion criteria

Exclusion criteria: 1.Merge congenital or acquired coagulation dysfunction; 2.Severe liver and kidney dysfunction; 3.Active infection; 4. thrombosis or bleeding related diseases: (1) VTE or arterial thrombotic events were diagnosed within 3 months before enrollment; (2) Recent (within 1 month) history of severe bleeding (BARC grade 3-5); (3) Contraindications to anticoagulant therapy exist (such as platelet count<50 × 10^9 /L, allergic history)

Design outcomes

Primary

MeasureTime frame
D-dimer FDP?TAT?t-PAIC?PIC?TM;

Countries

China

Contacts

Public ContactShi Xiaohong

Shandong Provincial Qianfoshan Hospital

s20739@163.com+86 531 89269681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026